02 July 2026 - Gold producer Native Mineral Resources Holdings Limited (ASX: NMR) has entered its third convertible security funding agreement, bolstering capital for debt management and strategic initiatives.
02 July 2026 - The radiopharmaceutical company gains regulatory clearance to advance Part 2 of its ProstACT Global Phase 3 study for TLX591-Tx in metastatic castration-resistant prostate cancer.
02 July 2026 - ASX-listed BCAL Diagnostics invests $1.39 million for 10.2% of molecular diagnostics firm, aiming to expand market reach and leverage complementary capabilities.
02 July 2026 - The radiopharmaceutical firm achieves 11% revenue growth and expands US footprint, but clinical guideline finalisation pushes short-term installation targets.
02 July 2026 - ASX-listed B2B funder Butn Limited divests Smash Repair Factoring Business for $4.1 million and amends corporate credit facility to streamline operations and reduce costs.